Skip to main content
. 2016 Nov 3;11(11):e0165672. doi: 10.1371/journal.pone.0165672

Table 3. Clinical outcomes with different reperfusion strategies.

Variables Fibrinolysis (N = 160) Primary PCI (N = 1000) No reperfusion (N = 1922) P value
Death 24 (15.0%) 77 (7.7%) 383 (19.9%) <0.001
 Cardiac death 23 (14.4%) 73 (7.3%) 357 (18.6%) <0.001
 Non-cardiac death 1 (0.6%) 4 (0.6%) 26 (1.4%) 0.028
Recurrent MI 3 (1.9%) 7 (0.7%) 16 (0.8%) 0.412
Ischemia driven revascularization 0 (0.0%) 9 (0.9%) 3 (0.2%) 0.007
MI-related complications
Heart failure 46 (28.8%) 177 (17.7%) 636 (33.1%) <0.001
Mechanical complications 3 (1.9%) 5 (0.5%) 35 (1.8%) 0.006
VT/VF 7 (7.5%) 32 (5.2%) 65 (5.1%) 0.636
Cardiac arrest 10 (6.3%) 36 (3.6%) 192 (10.0%) <0.001
Cerebral events 3 (1.9%) 17 (1.7%) 29 (1.5%) 0.889
Hemorrhage stroke 1 (0.6%) 3 (0.3%) 1 (0.1%) 0.094
Other major bleeding 8 (5.0%) 30 (3.0%) 59 (3.1%) 0.439
Transfusion 1 (0.6%) 9 (0.9%) 11 (0.6%) 0.605
IABP support 1 (0.6%) 73 (7.3%) 31 (1.6%) <0.001
Pulmonary embolism 0 (0.0%) 0 (0.0%) 3 (0.2%) 0.244
ICU or CCU stay (d) 4 (1, 7) 3 (2, 6) 3 (0, 7) <0.001
Normal ward stay (d) 6 (0, 11) 5 (3, 8) 5 (1, 10) 0.606

MI, myocardial infarction; VT/VF, ventricular tachycardia/ventricular fibrillation; IABP, intra-aortic balloon pump; ICU, intensive care unit; CCU, coronary care unit.